Hakutulokset - Witjes, Han
- Näytetään 1 - 10 yhteensä 10 tuloksesta
-
1
-
2
-
3
Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation Tekijä Frattarelli, John L, Hillensjö, Torbjörn, Broekmans, Frank J, Witjes, Han, Elbers, Jolanda, Gordon, Keith, Mannaerts, Bernadette
Julkaistu 2013Teksti -
4
Population pharmacokinetics and exposure‐response of osimertinib in patients with non‐small cell lung cancer Tekijä Brown, Kathryn, Comisar, Craig, Witjes, Han, Maringwa, John, de Greef, Rik, Vishwanathan, Karthick, Cantarini, Mireille, Cox, Eugène
Julkaistu 2017Teksti -
5
Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol Tekijä Broekmans, Frank J., Verweij, Pierre J.M., Eijkemans, Marinus J.C., Mannaerts, Bernadette M.J.L., Witjes, Han
Julkaistu 2014Teksti -
6
Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Tekijä Lommerse, Jos, Clarke, Diana, Kerbusch, Thomas, Merdjan, Henri, Witjes, Han, Teppler, Hedy, Mirochnick, Mark, Acosta, Edward P., Wenning, Larissa, Nachman, Sharon, Chain, Anne
Julkaistu 2019Teksti -
7
Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia Tekijä Du, Lihong, Wenning, Larissa, Migoya, Elizabeth, Xu, Yan, Carvalho, Brendan, Brookfield, Kathleen, Witjes, Han, de Greef, Rik, Lumbiganon, Pisake, Sangkomkamhang, Ussanee, Titapant, Vitaya, Duley, Lelia, Long, Qian, Oladapo, Olufemi T.
Julkaistu 2018Teksti -
8
Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure‐Response Modeling and Simulation Study Tekijä Du, Lihong, Wenning, Larissa A., Carvalho, Brendan, Duley, Lelia, Brookfield, Kathleen F., Witjes, Han, de Greef, Rik, Lumbiganon, Pisake, Titapant, Vitaya, Kongwattanakul, Kiattisak, Long, Qian, Sangkomkamhang, Ussanee S., Gülmezoglu, Ahmet M., Oladapo, Olufemi T.
Julkaistu 2019Teksti -
9
998. Forward and Reverse Translational Approaches to Predict Efficacy of the Neutralizing Respiratory Syncytial Virus (RSV) Antibody MK-1654 Tekijä Maas, Brian M, Lommerse, Jos, Plock, Nele, Railkar, Radha, Amy Cheung, S Y, Caro, Luzelena, Chen, Jingxian, Liu, Wen, Zhang, Ying, Huang, Qinlei, Gao, Wei, Qin, Li, Meng, Jie, Witjes, Han, Schindler, Emilie, Guiastrennec, Benjamin, Bellanti, Francesco, Spellman, Daniel, Roadcap, Brad, Kalinova, Mariya, Fok-Seang, Juin, Catchpole, Andrew P, Espeseth, Amy, Aubrey Stoch, S, Lai, Eseng, Vora, Kalpit A, Aliprantis, Antonios O, Sachs, Jeffrey R
Julkaistu 2021Teksti -
10
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis Tekijä Maas, Brian M., Lommerse, Jos, Plock, Nele, Railkar, Radha A., Cheung, S.Y. Amy, Caro, Luzelena, Chen, Jingxian, Liu, Wen, Zhang, Ying, Huang, Qinlei, Gao, Wei, Qin, Li, Meng, Jie, Witjes, Han, Schindler, Emilie, Guiastrennec, Benjamin, Bellanti, Francesco, Spellman, Daniel S., Roadcap, Brad, Kalinova, Mariya, Fok-Seang, Juin, Catchpole, Andrew P., Espeseth, Amy S., Stoch, S. Aubrey, Lai, Eseng, Vora, Kalpit A., Aliprantis, Antonios O., Sachs, Jeffrey R.
Julkaistu 2021Teksti